Completed OBSERVATIONAL NCT00619177

Assessing the Impact of MOVALIS in Osteoarthritis and Rheumatoid Arthritis Patients on Health Related Quality of Life

Assessing the Impact of MOVALIS on Health Related Quality of Life

Sponsor: Boehringer Ingelheim

Conditions Arthritis, Rheumatoid Osteoarthritis

Updated 8 times since 2017 Last updated: Jan 30, 2015 Started: Mar 31, 2007 Primary completion: May 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Arthritis, Rheumatoid and Osteoarthritis, this trial is completed. The trial is conducted by Boehringer Ingelheim and has accumulated 8 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Oct 2025 — Present [monthly]

Completed
Sep 2025 — Oct 2025 [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Mar 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Boehringer Ingelheim

Data source: Boehringer Ingelheim

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aš, Czechia , Babice, Czechia , Bardejov, Slovakia , Benesov Nad Ploucnicí, Czechia , Benesov U Prahy, Czechia , Benešov, Czechia , Benátky nad Jizerou, Czechia , Beroun, Czechia , Blansko, Czechia , Blatnice pod Svatým Antonínkem, Czechia and 309 more locations